Hide
Show all
Email this article 
Molecular Docking Study of Nutmeg (Myristica Fragrans) Constituents as Anti-Skin Cancer Agents
Abstract
Molecular docking analysis was carried out to understand better the interaction between DHODH and inhibitor from nutmeg in this series. The nutmeg constituent binding orientations in the active site of DHODH was seen in a molecular docking analysis and helped design a potentially new inhibitor. This work aimed to study the molecular docking of nutmeg constituents with the DHODH inhibitor using a computer-aided drug design. Molecular docking using AutoDock 4.2 was done to explore the models of binding complexes. The 3D structure was derived using Discovery Studio to investigate the essential chemical interaction of complex structures. Dihydroguaiaretic acid was the most potent ligand having a docking score of -9.3 kcal/mol. This value was better than the standard drug 5-FU. The dihydroguaiaretic acid structure interacted with Tyr365 and Thr63 through a hydrogen bond similar to the native ligand. These results suggest that nutmeg seed could serve as the lead compound for potent DHODH inhibitors against skin.
Keywords
Full Text:
PDFReferences
K. Lee, S. Mun, H. Pyun, M. Kim, & J. Hwang, "Effects of Macelignan Isolated from Myristica fragrans ( Nutmeg ) on Expression of Matrix Metalloproteinase-1 and Type I Procollagen in UVB-Irradiated Human Skin Fibroblasts,"Biological and Pharmaceutical Bulletin vol. 35, no. October, pp. 1669–1675, 2012.
Y. F. Dhaslin, R. Issac, & M. L. Prabha, "Antioxidant , antimicrobial , and health benefits of nutmeg," Drug Invention Today, vol. 12, no. 1, pp. 2018–2020, 2019.
DOI: 10.1016/B978-0-12-375688-6.10098-2
C. Zhang, E. Jayashree, P. S. Kumar, & M. G. Nair, "NPC Natural Product Communications," Natural Product Communicationspp. 8–11, 2015.
S. R. Abbas & S. Baig, "Treatment of Skin Cancer by Medicinal Plants [ A review ]," Journal of biotechnological sciences (vol. 137, no. 2, pp. 131–137, 2020.
H. Chen, J. Nadas, A. Bode, & K. Yao, "Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods," PloS one,vol. 7, no. 5, 2012.
DOI: 10.1371/journal.pone.0038261
J. Chavda & H. Bhatt, "3D-QSAR ( CoMFA , CoMSIA , HQSAR and topomer CoMFA ), MD simulations and molecular docking studies on purinylpyridine derivatives as B-Raf inhibitors for the treatment of melanoma cancer," Structural Chemistry,2019.
DOI: 10.1007/s11224-019-01334-9
M. Hosseini, L. Dousset, P. Michon, & W. Mahfouf "UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis," Oncogenesis, vol. 8, no. 10, 2019.
DOI: 10.1038/s41389-019-0161-z
Y. Qian, X. Liang, P. Kong, Y. Cheng, H. Cui, T. Yan, “Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma,” Cell Death Dis., vol. 11, no. 10, pp. 1–13, 2020.
DOI: 10.1038/s41419-020-03044-1
A. K. M. Fairus, B. Choudhary, S. Hosahalli, N. Kavitha, & O. Shatrah, "Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells," Biochimie, vol. 135, pp. 154–163, 2017.
DOI: 10.1016/j.biochi.2017.02.003Get
U. D. Uysal, D. Ercengiz, O. Karaosmanoğlu, B. Berber, H. Sivas, & H. Berber, "Theoretical and experimental electronic transition behaviour study of 2-((4-(dimethylamino)benzylidene)amino)-4-methylphenol and its cytotoxicity," J. Mol. Struct., vol. 1227, no. xxxx, 2021.
DOI: 10.1016/j.molstruc.2020.129370
M.J.G.W. Ladds, & I.M.M. Van Leeuwen "A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage," Nat. Commun., vol. 9, no. 1, 2018.
DOI: 10.1038/s41467-018-03441-3
S. Christian, C. Merz, L .Evans, S. Gradl, &H. Seidel "The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies," Leukemia, vol. 33, no. 10, pp. 2403–2415, 2019.
DOI: 10.1038/s41375-019-0461-5
L. Li, S.R. Ng, C.I. Colón, B.J. Drapkin, "Identification of DHODH as a therapeutic target in small cell lung cancer," Sci. Transl. Med., vol. 11, no. 517, 2019.
DOI: 10.1126/scitranslmed.aaw7852
O. N. Reva, S. Rademan, M. H. Visagie, M. T. Lebelo, and V. Mokgadi, "Comparison of structures and cytotoxicity of mupirocin and batumin against melanoma and several other cancer cell lines,"Future medicinal chemistry, vol.1, no.7, pp. 677-691.2019.
Z. Zabiulla, V. H. Malojirao, Y. Hussein, E. Mohammed, P. Thirusangu, & S. A. Khanum, "CHEMISTRY Synthesis , molecular docking , and apoptogenic ef fi cacy of novel N- heterocycle analogs to target B-cell lymphoma 2 / X-linked inhibitors of apoptosis proteins to regress melanoma," Med. Chem. Res., pp. 1132–1160, 2019.
DOI: 10.1007/s00044-019-02357-x
J. De Ruyck & G. Brysbaert, "Molecular docking as a popular tool in drug design , an in silico travel," Advances and applications in bioinformatics and chemistry: AABC, vol.9, no. 1, pp. 1–11, 2016.
G. Kirishnamaline, J. D. Magdaline, T. Chithambarathanu, D. Aruldhas, & A. R. Anuf, "Theoretical investigation of structure, anti-cancer activity and molecular docking of thiourea derivatives," J. Mol. Struct., vol. 1225, 2021.
DOI: 10.1016/j.molstruc.2020.129118
R. S. Ibrahim & A. A. El-Banna, "Network pharmacology-based analysis for unraveling potential cancer-related molecular targets of Egyptian propolis phytoconstituents accompanied with molecular docking and in vitro studies ," RSC Adv., vol. 11, no. 19, pp. 11610–11626, 2021.
S.A. Galal, A.S. Abdelsamie, H. Tokuda,& N. Suzuki, "Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives," Eur. J. Med. Chem., vol. 46, no. 1, pp. 327–340, 2011.
DOI: 10.1016/j.ejmech.2010.11.022
R. Baumgartner, M. Walloschek, M. Kralik, "Dual binding mode of a novel series of DHODH inhibitors," J. Med. Chem., vol. 49, no. 4, pp. 1239–1247, 2006.
T. Narsinghani & M. C. Sharma, "CHEMISTRY Synthesis , docking studies and antioxidant activity of some chalcone and aurone derivatives," Medicinal Chemistry Research, vol.22, no.9, pp. 4059-4068,2012.
DOI: 10.1007/s00044-012-0413-3
Y.Y. Yang, Z.Y. Wu, H. Zhang, S.J. Yin, F.B. Xia, Q. Zhang, "LC-MS-based multivariate statistical analysis for the screening of potential thrombin/factor Xa inhibitors from Radix Salvia Miltiorrhiza," Chinese Med. (United Kingdom), vol. 15, no. 1, pp. 1–13, 2020.
DOI: 10.1186/s13020-020-00320-2
M. Alagumuthu & S. Arumugam, "Molecular explorations of substituted 2 ‑( 4 ‑ phenylquinolin ‑ 2 ‑ yl ) phenols as phosphoinositide 3 ‑ kinase inhibitors and anti-cancer agents," Cancer chemotherapy and pharmacology, vol.79, no.2, pp 389-397.,2017.
DOI: 10.1007/s00280-016-3227-z
M. Arciniega & J. L. Medina-franco, "Molecular docking : current advances and challenges," no. May, pp. 0–23, 2018.
DOI: 10.22201/fesz.23958723e.2018.0.143
M. Gaba, A. Shaheed, B. Ajit, S. Jujhar, & S. Memorial, "An overview on Molecular Docking International Journal of Drug Development & Research, JSM Chem, vol.4, no.2, pp.1024-1028.2015.
I. A. Guedes, C. S. De "Magalhães, & L. E. Dardenne, “Receptor – ligand molecular docking,” Biophysical reviews, vol.6, no.1, pp.75-87,2013.
DOI: 10.1007/s12551-013-0130-2"
A. D. Gupta & D. Rajpurohit, "Antioxidant and Antimicrobial Activity of Nutmeg (Myristica fragrans)," Nuts Seeds Heal. Dis. Prev., pp. 831–839, 2011.
DOI: 10.1016/B978-0-12-375688-6.10098-2"
V. Kuete, Myristica fragrans: A Review. Elsevier Inc., 2017.
DOI: 10.1016/B978-0-12-809286-6.00023-6"
A. Piras, A. Rosa, B. Marongiu, & A. Atzeri., "Extraction and Separation of Volatile and Fixed Oils from Seeds of Myristica fragrans by Supercritical CO 2: Chemical Composition and Cytotoxic Activity on Caco-2 Cancer Cells," J. Food Sci., vol. 77, no. 4, pp. 1–6, 2012.
DOI: 10.1111/j.1750-3841.2012.02618.x"
S.M. Osman, N.A. Ayoub, S.A. Hafez,& H.A. Ibrahim, "Aldose reductase inhibitor form Cassia glauca: A comparative study of cytotoxic activity with Ag nanoparticles (NPs) and molecular docking evaluation," PLoS One, vol. 15, no. 10 October, 2020.
DOI: 10.1371/journal.pone.0240856x"
M. Sargolzaei, "Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study," J. Mol. Graph. Model., vol. 103, p. 107803, 2021.
DOI: 10.1016/j.jmgm.2020.107803"
P. Ghosh, S. Bhakta, & M. Bhattacharya "A Novel Multi-Epitopic Peptide Vaccine Candidate Against Helicobacter pylori: In-Silico Identification, Design, Cloning and Validation Through Molecular Dynamics," Int. J. Pept. Res. Ther., no. 0123456789, 2021.
DOI: 10.1007/s10989-020-10157-w"
M. C. Vlasiou & K. S. Pafti, "Screening possible drug molecules for Covid-19. The example of vanadium (III/IV/V) complex molecules with computational chemistry and molecular docking," Comput. Toxicol., vol. 18, no. August 2020, 2021.
DOI: 10.1016/j.comtox.2021.100157
X. Lin, X. Li, & X. Lin, "A review on applications of computational methods in drug screening and design," Molecules, vol. 25, no. 6, pp. 1–17, 2020.
DOI: 10.3390/molecules25061375
X.-Y. Meng, H.-X. Zhang, M. Mezei, & M. Cui, "Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery," Curr. Comput. Aided-Drug Des., vol. 7, no. 2, pp. 146–157, 2012.
DOI: 10.2174/1573409117956776025"
F. Rahman, S. Tabrez, R. Ali, A. S. Alqahtani, M. Z. Ahmed, & A. Rub, "Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins," J. Tradit. Complement. Med., vol. 11, no. 2, pp. 173–179, 2021.
DOI: 10.1016/j.jtcme.2021.01.006"
L. Metterle, C. Nelson, & N. Patel, "Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review," J. Am. Acad. Dermatol., vol. 74, no. 3, pp. 552–557, 2016.
DOI: 10.1016/j.jaad.2015.09.040"
D.M Rata, A.N Cadinoiu, L.I Atanase&, M. Popa, "Topical formulations containing aptamer-functionalized nanocapsules loaded with 5-fluorouracil - An innovative concept for the skin cancer therapy," Mater. Sci. Eng. C, vol. 119, no. 11, p. 111591, 2021.
DOI: 10.1016/j.msec.2020.111591"
E. A. A. A. T. El-alfy, "Chemical diversity and pharmacological significance of the secondary metabolites of nutmeg ( Myristica fragrans Houtt .)," Phytochem. Rev., 2016.
DOI: 10.1007/s11101-016-9469-x"
A.R Zuo, H.H Dong, Y.Y Yu, Q.L Shu, L.X Zheng,& X.Y Yu, "The antityrosinase and antioxidant activities of flavonoids dominated by the number and location of phenolic hydroxyl groups," Chinese Med. (United Kingdom), vol. 13, no. 1, pp. 1–12, 2018.
DOI: 10.1186/s13020-018-0206-9"
Y. Zhang, X. Mao, J. Su, Y. Geng, R. Guo, "A network pharmacology-based strategy deciphers the underlying molecular mechanisms of Qixuehe Capsule in the treatment of menstrual disorders," Chinese Med. (United Kingdom), vol. 12, no. 1, pp. 1–11, 2017.
Refbacks
- There are currently no refbacks.
